Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Active specific immunotherapy of human solid tumors.

Annals of the New York Academy of Sciences

|January 1, 1976

Summary

This summary is machine-generated.

Active specific immunotherapy using enzyme-altered cells shows promise for human solid tumors. Continued research is warranted, focusing on in vitro assays for monitoring immunity and detecting adverse effects as adjuvant therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Protracted survival after resection of metastatic uveal melanoma.

Cancer·2000

Same author

Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.

Cancer·2000

Same author

Five risk factors identify patients with gastroesophageal intussusception.

Archives of surgery (Chicago, Ill. : 1960)·1999

Same author

The consequences of a major bile duct injury during laparoscopic cholecystectomy.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·1998

Same author

Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer.

Annals of surgery·1997

Same author

Improved staging of liver tumors using laparoscopic intraoperative ultrasound.

Journal of surgical oncology·1997

Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026

Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026

Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026

Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026

Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026

Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026

See all related articles

Area of Science:

Oncology
Immunology

Background:

Active specific immunotherapy (ASI) is being explored for treating human solid tumors.
Enzyme-altered cells represent a potential modality for ASI.

Purpose of the Study:

To evaluate the feasibility of ASI using enzyme-altered cells in human solid tumors.
To assess the safety and efficacy of this immunotherapy approach.
To emphasize the importance of in vitro assays in immunotherapy programs.

Main Methods:

Utilized enzyme-altered cells for active specific immunotherapy in patients with solid tumors.
Employed in vitro assay methods to document immune enhancement.
Expanded test methods for early detection of adverse effects.

Main Results:

Related Experiment Videos

The approach of ASI using enzyme-altered cells appears feasible for human solid tumors.
Initial results suggest no adverse clinical effects from the treatment.
In vitro assays are crucial for documenting immune response.

Conclusions:

Active specific immunotherapy with enzyme-altered cells is a feasible adjuvant treatment for solid tumors.
Continued research is necessary to optimize this approach.
Robust in vitro monitoring is essential for safety and efficacy assessment.